首页 | 本学科首页   官方微博 | 高级检索  
检索        

CD3AK细胞结合中药治疗原发性肝癌的疗效初步观察
引用本文:莫钦国,梁安民,蒙子卿.CD3AK细胞结合中药治疗原发性肝癌的疗效初步观察[J].广西医学,1999,21(6):1074-1076.
作者姓名:莫钦国  梁安民  蒙子卿
作者单位:广西医科大学肿瘤医院
基金项目:广西区科委自然科学基金!(930 60 83)
摘    要:目的;观察CD3AK细胞结合中药制剂-消癌胶囊治疗原发性肝癌的效果。方法:选择确诊为不能切除的中晚期肝癌患者119例,随机分为三组,A组30例采用CD3AK细胞结合消癌胶囊治疗,B组44例单用CDAK细胞治疗,C组45例单用化疗。结果:A,B,C组部分缓解率分别为30%,20.5%,17.75,同时A,B两组患者治疗后T细胞亚群CD^+3,CDE^+4,CD^+8有不同程度提高。

关 键 词:肝肿瘤  CD3AK细胞  原发性  中西医结合治疗

Observations on the curative effect of CD 3AK Cells combined with traditional Chinese medicine in treating hepatocellular cancer
Mo Qinguo,Liang Anmin,Meng Ziqing.Observations on the curative effect of CD 3AK Cells combined with traditional Chinese medicine in treating hepatocellular cancer[J].Guangxi Medical Journal,1999,21(6):1074-1076.
Authors:Mo Qinguo  Liang Anmin  Meng Ziqing
Institution:Nanning 530021
Abstract:Objective:To observe the curative effect of CD 3AK cells combined with Traditional Chinese Medicine-xiaoai jiaonang in treating hepatocelluar cancer(HCC) Methods:The clinical trial were performed on 119 patients with HCC which were divided into Group A(CD 3AK cells+xiaoai jiaonang,30 cases),group B(CD 3AK alone,44 cases),Group C(Chemotherapy alone,45 cases) Results:The rates of the part remission in clinical trial were 30% in Group A,20 5% in Group B,and 17 7% in Group C The percentage of T cell subsets CD + 3,CD + 4,CD + 8 increased,and the sIL-2R levels decreased in the patients of Group A and B after treatment Conclusion:The results indicated that the therapy of the CD 3AK cells combined with Traditional Chinese Medicine-Xiaoai jiaonang is an effective means in treating HCC
Keywords:Liver neoplasms  CD  3AK cell  Traditional Chinese medicine
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号